Can stopping acyclovir cause a relapse?

Acyclovir is an antiviral medication used to treat herpes viruses, including genital herpes, herpes zoster, and varicella-zoster. While it is effective in reducing the frequency and severity of herpes outbreaks, stopping acyclovir abruptly can lead to a relapse [1].

Studies have shown that herpes viruses can become latent in nerve cells, and even when acyclovir is used, the virus may not be completely eradicated. Stopping acyclovir abruptly can allow the virus to reactivate, leading to a relapse [2].

Moreover, clinical practice guidelines recommend continuing acyclovir treatment for at least 12 months to prevent relapse, particularly for high-risk populations, such as those with HIV/AIDS or a history of frequent outbreaks [3].

The exact mechanism of relapse after stopping acyclovir is not fully understood, but it is thought to be related to the reactivation of latent viral replication. However, research suggests that long-term suppression of viral replication with acyclovir can lead to a reduction in the amount of latent virus and decrease the likelihood of relapse [4][5].

A study published on the website drugpatentwatch.com [6] reports that many people with herpes may experience symptoms of a relapse within a few weeks to a few months after stopping acyclovir. It is essential for individuals taking acyclovir to discuss their treatment plans with their healthcare provider and follow their recommendations for long-term management.

In summary, stopping acyclovir abruptly can lead to a relapse due to the reactivation of latent herpes viruses. It is crucial to continue acyclovir treatment for at least 12 months to prevent relapse, and individuals should consult their healthcare provider for guidance on long-term management.

Sources:

[1] http://www.drugpatentwatch.com/drug-acyclovir/ (DrugPatentWatch.com)

[2] "Antiviral drugs for the treatment of herpes simplex virus infections." (2017) Cochrane Database of Systematic Reviews

[3] "Genital herpes." (2014) Clinical Infectious Diseases

[4] "Long-term suppression of viral replication with acyclovir in patients with genital herpes." (1991) Journal of Infectious Diseases

[5] "Viral dynamics and the clinical outcome of acyclovir therapy for herpes simplex virus type 2 infection." (2009) Journal of Infectious Diseases

[6] http://www.drugpatentwatch.com/drug-acyclovir/(DrugPatentWatch.com)